Anatomical Extent of Pelvic Lymphadenectomy in Patients Undergoing Radical Prostatectomy{A figure is presented}

European Urology

Volumn 52, Issue 1, 2007, Pages 29-37

  Heidenreich, Axel ^a   Ohlmann, Carsten H ^a   Polyakov, Sergej ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Research Institute of Oncology and Medical Radiology of the Ministry of Health of the Byelorussian SSR   (Belarus)

Author keywords

Complications; Lymph node dissection; Lymph node metastases; Prognosis; Radical prostatectomy; Staging

Indexed keywords

BLEEDING; CANCER CLASSIFICATION; CANCER GROWTH; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL STUDY; DEEP VEIN THROMBOSIS; HEART INFARCTION; HUMAN; INTERNAL ILIAC ARTERY; LUNG EMBOLISM; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHEDEMA; LYMPHOCELE; MEDICAL LITERATURE; NERVE INJURY; PELVIS LYMPHADENECTOMY; PNEUMONIA; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; URETER INJURY;

HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; PELVIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 34249057154     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.04.020     Document Type: Review

References (52)

1. Gil-Vernet J.M. Prostate cancer: anatomical and surgical considerations. Brit J Urol 78 (1996) 161-168
2. Crawford E.D., Batuello J.T., Snow P., et al. The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma. Cancer 88 (2000) 2105-2109
3. Batuello J.T., Gamito E.J., Crawford E.D., et al. Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer. Urology 57 (2001) 481-485
4. Partin A.W., Kattan M.W., Subing E.N.P., et al. Combination of prostate-specific antigen, clinical stage, and Gleason sum to predict pathological stage of localized prostate cancer: a multi-institutional update. JAMA 277 (1997) 1445-1451
5. Briganti A., Chun F.K., Salonia A., et al. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer. BJU Int 98 (2006) 788-793
6. Briganti A., Chun F.K., Salonia A., et al. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 49 (2006) 1019-1027
7. Heidenreich A. Editorial Comment. Eur Urol 49 (2006) 1026-1027
8. Leissner J., Hohenfellner R., Thüroff J.W., and Wolf H.K. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder: significance for staging and prognosis. BJU Int 85 (2000) 817-821
9. Yildirim E., Celen O., and Berberoglu U. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?. J Am Coll Surg 192 (2001) 25-37
10. Kato H. Lymph node dissection for thoracic esophageal carcinoma. Two- and 3-field lymph node dissection. Ann Chir Gynaecol 84 (1995) 193-199
11. Algari M., Colton M.D., Seidmon E.J., Greenberg R.E., and Hanno P.M. The staging pelvic lymphadenectomy: implication as an adjunctive procedure for clinically localized prostate cancer. J Urol 162 (1997) 243-246
12. Bader P., Burkhard F.C., Markwalder R., and Studer U.E. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?. J Urol 169 (2003) 849-854
13. Heidenreich A., von Knobloch R., and Varga Z. Extended pelvic lymphadenectomy inpatients undergoing radical prostatectomy in prostate cancer: high incidence of lymph node metastases. J Urol 167 (2001) 1681-1684
14. Heidenreich A, von Knobloch R, Varga Z, Hofmann R. Extended pelvic lymphadenectomy in men undergoing radical retropubic prostatectomy-data on >300 cases. Proc ASCO 2005;22:409s (abstract no. 4612).
15. Weingärtner K., Ramaswamy A., Bittinger A., Gerharz E.W., Vöge D., and Riedmiller H. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol 156 (1996) 1969-1971
16. Stone N.N., Stock R.G., and Unger P. Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified technique. J Urol 158 (1997) 1891-1894
17. Wawroschek F., Vogt H., Wengenmair H., et al. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Urol Int 70 (2003) 303-310
18. Narayan P., Fournier G., Gajendran V., et al. Utility of preoperative serum prostate specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer. Urology 44 (1994) 519-524
19. Bluestein D.L., Bostwick D.G., Bergstralh E.J., and Oesterling J.E. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 151 (1994) 1315-1320
20. Conrad S., Graefen M., Pichlmaier U., Henke R.P., Hammerer P.G., and Huland H. Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases inpatients with clinically localized prostatic carcinoma. J Urol 159 (1998) 2023-2029
21. Conrad S., Graefen M., Pichlmaer U., et al. Prospective validation of an algoithm with systematic sextant biopsy to predict lymph node metastasis in patients with clinically localized prostatic carcinoma. J Urol 167 (2002) 521-525
22. Haese A., Epstein J.I., Huland H., and Partin A.W. Validation of a biopsy based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma. Cancer 95 (2002) 1016-1021
23. Naya Y., and Babaian R.J. The predictors of pelvic lymph node metastasis at radical retropubic prostatectomy. J Urol 170 (2003) 2306-2310
24. Heidenreich A., Ohlmann C., Engelmann U., Schumacher M., and Studer U. Partin tables do not adequately predict the risk of lymph node involvement in patients undergoing radical prostatectomy for clinically localized prostate cancer. Eur Urol Suppl 5 (2006) 280 (abstract no. 1032)
25. Allaf M.E., Palapattu G.S., Trock B.J., Carter H.B., and Walsh P.C. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 172 (2004) 1840-1844
26. Joslyn S.A., and Konety B.R. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 68 (2006) 121-125
27. Weckermann D., Goppelt M., Dorn R., Wawroschek F., and Harzmann R. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate specific antigen (PSA) level of < or = 10 ng/ml and biopsy Gleason score of < or = 6, and their influence on PSA progression-free survival after radical prostatectomy. BJU Int 97 (2006) 1173-1178
28. Schuhmacher M.C., Burkhard F.C., Thalmann G.N., Fleischmann A., and Studer U.E. Is pelvic lymph node dissection necessary in patients with a serum PSA < 10 ng/ml undergoing radical prostatectomy for prostate cancer?. Eur Urol 50 (2006) 272-279
29. Dillioglugil J.F., Leibman B.D., Leibman N.S., Kattan M.W., Rosas A.L., and Scardino P.T. Risk factors for complications and morbidity after radical retropubic prostatectomy. J Urol 157 (1997) 1760-1767
30. Clark T., Parekh D.J., Cookson M.S., et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 169 (2003) 145-148
31. Briganti A., Chun F.K.-H., Salonia A., et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 50 (2006) 1006-1013
32. Burkhard F.C., Kessler T.M., Fleischmann A., Thalmann G.N., Schuhmacher M., and Studer U.E. Nerve sparing open radical retropubic prostatectomy[e]does it have an impact on urinary continence?. J Urol 176 (2006) 189-195
33. Michl U.H., Friedrich M.G., Graefen M., Haese A., Heinzer H., and Huland H. Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomy. J Urol 176 (2006) 227-231
34. El-Bahnasawy M.S., El-Assmy A., Dawood A., et al. Effect of the use of internal iliac artery for renal transplantation on penile vascularity and erectile function: a prospective study. J Urol 172 (2004) 2335-2339
35. Fergany A., Kupelian P.A., Levin H.S., Zippe C.D., Reddy C., and Klein E.A. No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients. Urology 56 (2000) 92-95
36. Meng M.V., and Carroll P.R. When is pelvic lymph node dissection necessary before radical prostatectomy? A decision analysis. J Urol 164 (2000) 1235-1240
37. El-Galley R.E.S., Keane T.E., Petros J.A., et al. Evaluation of staging lymphadenectomy in prostate cancer. Urology 52 (1998) 663-667
38. Cheng L., Zincke H., Blute M.L., Bergstralh E.J., Scherer B., and Bostwick D.G. Risk of prostate cancer death in patients with lymph node metastasis. Cancer 91 (2001) 66-71
39. Hull G.W., Rabbani F., Abbas F., Wheeler T.M., Kattan M.W., and Scardino P.T. Cancer control with radical prostatectomy alone in 1000 consecutive patients. J Urol 167 (2002) 528-534
40. Steinberg G.D., Epstein J.I., Piantadosi S., and Walsh P.C. Management of stage D1 adenocarcinoma of the prostate: the Johns Hopkins experience 1974 to 1987. J Urol 144 (1990) 1425-1432
41. Daneshmand S., Quek M.L., Stein J.P., et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 172 (2004) 2252-2255
42. Bader P., Spahn M., Huber R., Echtle D., and Frohneberg D. Limited lymph node dissection in prostate cancer may miss lymph node metastases and determines outcome of apparently pN0 prostate cancer. Eur Urol Suppl 3 2 (2004) 16 (abstract no. 55)
43. Masterson T.A., Bianco Jr. F.J., Vickers A.J., et al. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol 175 (2006) 1320-1324
44. Wawroschek F., Wagner T., Hamm M., et al. The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. Eur Urol 43 (2003) 132-137
45. DiMArco D.S., Zincke H., Sebo T.J., Slezak J., Bergstralh E.J., and Blute M.L. The extent of pelvic lymphadenectomy for pTxN0 prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. J Urol 173 (2005) 1121-1125
46. Messing E.M., Manola J., Sarosdy M., Wilding G., Crawford E.D., and Trump D.I. Immediate hormonal therapy versus observation after radical prostatectomy and pelvic lymphadenectomy for node positive prostate cancer. N Engl J Med 341 (1999) 1781-1788
47. Messing E.M., Manola J., Yao J., et al., Eastern Cooperative Oncology Group study EST 3886. Immediate hormonal therapy versus observation after radical prostatectomy and pelvic lymphadenectomy for node positive prostate cancer. Lancet Oncol 7 (2006) 472-479
48. Jeschke S., Nambirajan T., Leeb K., Ziegerhofer J., Sega W., and Janetschek G. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 173 (2005) 1943-1946
49. Corvin S., Schilling D., Eichhorn K., et al. Laparoscopic sentinel lymph node dissection-a novel technique for staging of prostate cancer. Eur Urol 49 (2006) 280-285
50. Brenot-Rossi I., Bastide C., Garcia S., et al. Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study. Eur J Nucl Med Mol Imag 32 (2005) 635-640
51. Weckermann D., Dorn R., Holl G., Wagner T., and Harzmann R. Limitations of radioguided surgery in high-risk prostate cancer. Eur Urol 51 (2007) 1549-1558
52. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph node metastases in prostate cancer. N Engl J Med 348 (2003) 2491-2499